Arthritis Research UK Gout Treatment Trial - Phase 2
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01477346|
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : January 5, 2017
|Condition or disease||Intervention/treatment||Phase|
|Gout||Other: Nurse intervention Other: Standard care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||517 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||October 2016|
|Actual Study Completion Date :||October 2016|
Nurse led package of care based on current recommended best practice.
Other: Nurse intervention
Complex package of care involving patient information and advice concerning lifestyle modification and recommended drug therapy.
Continuing standard general practitioner led care
Other: Standard care
Continuing standard General Practitioner led care.
- Reduction in serum uric acid levels [ Time Frame: 2 years ]
- Reduction in number of self reported acute attacks during year 2 [ Time Frame: 2 years ]
- Improved Quality of Life scores at study end [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01477346
|Academic Rheumatology, University of Nottingham|
|Nottingham, United Kingdom, NG5 1PB|
|Principal Investigator:||Michael Doherty, MA MD FRCP||University of Nottingham|